Board Meetings for ARTEMISMED

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
ARTEMISMEDArtemis Medicare Services Limited04 Jun 2026Other business mattersTo consider and approve the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds
ARTEMISMEDArtemis Medicare Services Limited04 Jun 2026Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 04-Jun-2026 to consider Other business.
ARTEMISMEDArtemis Medicare Services Limited08 May 2026Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 08-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
ARTEMISMEDArtemis Medicare Services Limited08 May 2026Financial ResultsTo consider and approve Audited Financial Results and recommendation of dividend, If any.
ARTEMISMEDArtemis Medicare Services Limited02 Feb 2026Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Fund raising.
ARTEMISMEDArtemis Medicare Services Limited02 Feb 2026Financial Results/Fund RaisingTo consider and approve (i) the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31, 2025; and (ii) the proposal for raising of funds by way of issuance of any instrument or security including equity shares, fully or partly convertible debentures, non-convertible debentures along with warrants, in one or more tranches, including by way of preferential allotment or a private placement (including one or more Qualified Institutions Placements).
ARTEMISMEDArtemis Medicare Services Limited11 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
ARTEMISMEDArtemis Medicare Services Limited11 Nov 2025Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
ARTEMISMEDArtemis Medicare Services Limited05 Aug 2025ARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 05-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .Board Meeting Intimation
ARTEMISMEDArtemis Medicare Services Limited05 Aug 2025Financial ResultsTo consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2025.
ARTEMISMEDArtemis Medicare Services Limited12 May 2025Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 12-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend.
ARTEMISMEDArtemis Medicare Services Limited12 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
ARTEMISMEDArtemis Medicare Services Limited05 Feb 2025Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 05-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
ARTEMISMEDArtemis Medicare Services Limited05 Feb 2025Financial ResultsTo consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31, 2024.
ARTEMISMEDArtemis Medicare Services Limited14 Nov 2024Board Meeting IntimationARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
Showing page 1 of 3 (44 total items)
Next